This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Driven by an older, more diverse population, along with a significant increase in riskfactors including high blood pressure and obesity, total costs related to cardiovasculardisease (CVD) conditions are likely to triple by 2050, according to recent projections. At least 6 in 10 U.S.
And plaque in your coronary arteries is the result of exposure to riskfactors over time. These individuals then must have had one or more riskfactors for a long time prior to their heart attack. 2 You will not know you have heartdisease by waiting for symptoms. The answer: RiskFactors.
Research Highlights: Asian American adults with more unfavorable factors related to income level, education, housing, access to health care and other social variables had a greater likelihood of having riskfactors for cardiovasculardisease in this.
Research Highlights: People living in neighborhoods with more environmental adversities, including pollution, toxic sites, high traffic and few parks, had higher rates of cardiovasculardisease and cardiovasculardiseaseriskfactors. This association.
A world without cardiovasculardisease (CVD) is possible, yet millions of lives are lost prematurely to heartdisease each year, according to the new report.
A projected rise in heartdisease and stroke – along with several key riskfactors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovasculardisease within the next 30 years, according to two new science reports. to 61% of the U.S.
Metal exposure from environmental pollution is associated with increased calcium buildup in the coronary arteries at a level comparable to traditional riskfactors, according to a new study.
Heersink School of Medicine have unveiled critical insights into the influence of high-proportion spliced-in titin truncating variants, or hiPSI TTNtv, on cardiovasculardiseaserisk. Physician-scientists from the University of Alabama at Birmingham Marnix E.
Pre-eclampsia and heart failure have common riskfactors, including hypertension, obesity and diabetes. It is not known whether heart failure increases the risk of pre-eclampsia. This study examines whether pregestational heart failure increases the risk of pre-eclampsia.
BackgroundEmerging genetic and observational evidence indicates that remnant cholesterol (RC) is a significant residual riskfactor for cardiovasculardiseases. Logistic regression was used to evaluate the risk of a high Gensini score associated with RC and lipid ratios.
Getty Images mtaschetta-millane Tue, 07/09/2024 - 07:23 July 9, 2024 — Disparities in cardiovasculardisease outcomes between urban and rural areas continue to widen, yet nearly half of U.S. and those in the South had the highest cardiovascularrisk index. counties do not have a practicing cardiologist. miles vs 87.1
A review in The Lancet finds that 20% of the world population carries a genetic riskfactor for cardiovasculardiseases such as heart attacks, strokes, and aortic valve stenosis: Increased levels of a lipid particle called lipoprotein(a). It is the most common genetic cause of cardiovasculardiseases.
Background Left ventricular (LV) mass is closely associated with atherosclerotic heartdisease, but the mechanisms are not well defined. This study aimed to evaluate the riskfactors associated with LV mass and subclinical coronary atherosclerosis, in an Asian population free of baseline cardiovasculardisease.
When it comes to cardiovasculardisease, two of the biggest riskfactors we must consider are: ApoB concentration - A measure of the number of circulating lipid particles. The greater the number of particles the artery wall is exposed to over time, the higher the risk of atherosclerosis and a heart attack 2.
A world without cardiovasculardisease (CVD) is possible, yet millions of lives are lost prematurely to heartdisease each year, according to the new Global Burden of Disease (GBD) special report published in the Journal of the American College of Cardiology.
The human capital approach was used to estimate productivity losses from morbidity and premature mortality due to cardiovascular conditions.RESULTS:One in 3 US adults received care for a cardiovascularriskfactor or condition in 2020.
When you have gotten all four crucial lifestyle factors wrong, you are only left with medications and procedures. Here are five things everyone should know about sleep and heartdisease. Remember, if you get sleep right, you seriously increase your odds of getting the other factors right. The problem is, it might be.
Many youth have heartdiseaseriskfactors by their late teens, and preventing or addressing these risks early may reduce the risk of developing cardiovasculardisease in the future, according to a new scientific statement.
Asian American adults with more unfavorable factors related to income level, education, housing, access to health care and other social variables had a greater likelihood of having riskfactors for cardiovasculardisease in this study.
A new JAMA study revealed that a shocking 90% of US adults are at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome, underscoring the need for preventative action before we face a wave of CKM-related heartdisease. Stage 4 (heartdisease, with or without kidney disease) – 9.2%
When I asked the readers of this newsletter about their experience of trying to get a comprehensive cardiovascularrisk assessment, the general feeling I got back was one of frustration. The majority of readers here are middle-aged and concerned about their future risk of heartdisease. So, no excuses there.
Journal of the American Heart Association, Ahead of Print. years of follow‐up, 385 incident CVD events (159 coronary heartdisease and 226 stroke) were documented. During the median 14.2 years 1.76), 1.72 (1.23–2.40), 2.40), and 2.49 (1.69–3.67), 3.67), respectively. 1.76), 1.72 (1.23–2.40), 2.40), and 2.49 (1.69–3.67),
Control of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV status with cardiovasculardisease (CVD), according to a study published online Jan. 16 in Clinical Infectious Diseases.
Recent studies have suggested that there may be a link between depression and heartdisease. Depression and heartdisease share many riskfactors, such as smoking, physical inactivity, and poor diet. There are several mechanisms by which depression may increase the risk of heartdisease.
Having more unfavorable social determinants of health, such as being unemployed, uninsured or not having education beyond high school, was associated with an increased likelihood of having riskfactors for cardiovasculardisease among Asian American adults, according to new research published today in the Journal of the American Heart Association. (..)
Aims:Asian Americans experience disproportionate burdens of cardiovascularriskfactors and cardiovasculardisease (CVD). However, the trends in cardiovascularrisks in adults from different Asian ethnic backgrounds remain understudied.
The 10 and 30year risks of total CVD, atherosclerotic CVD, coronary heartdisease, stroke, and heart failure (HF) were estimated for patients without CVD history at each time point (n=1242910), using the social deprivation indexenhanced Predicting Risk of CardiovascularDisease EVENTs equations.
Ballantyne, MD , emphasized that while fellows may consider prevention “boring,” it is crucial for avoiding resource-intensive late-stage cardiovasculardisease (CVD). He highlighted that cardiovascular health is essential for cognitive health, noting the common occurrence of vascular dementia.
Being heart healthy can prevent a heart attack or stroke by lowering your risk for heartdisease. To start you on the right path, there are several riskfactors that doctors will tell you to focus on.
Lipoprotein(a) (Lp[a]) can improve the accuracy of assessment of atherosclerotic cardiovasculardisease and the risk of aortic valve stenosis. Management of high levels encourages rigorous attention to correction of other riskfactors, such as blood pressure, smoking and low-density lipoprotein (LDL).
We assessed the association of cannabis use (number of days of cannabis use in the past 30 days) with self‐reported cardiovascular outcomes (coronary heartdisease, myocardial infarction, stroke, and a composite measure of all 3) in multivariable regression models, adjusting for tobacco use and other characteristics in adults 18 to 74 years old.
Exercise prevents and reverses cardiovasculardisease, but whether high-intensity exercise training (HIIT) is safe and effective for adults after minimally invasive heart surgery is unknown. Exercise is a wonder drug for cardiovasculardisease (CVD) prevention and reversal. Cardiac rehab works wonders.
Background Lipoprotein(a) [Lp(a)] is an independent riskfactor for cardiovasculardisease due to its unique apo(a) component and its association with atherosclerosis and thrombogenesis. Methods Randomized controlled trials (RCTs) were systematically searched in PubMed, the Cochrane Library, and other databases.
Moreover, it can play an important role in combating gender inequalities in cardiovasculardisease outcomes. From big data, AI can produce algorithms that individualise cardiac riskfactors and prevent perpetuating gender biases in diagnosis. Nonetheless, AI implementation requires caution.
Environmental toxicants and pollutants are causes of adverse health consequences, including well-established associations between environmental exposures and cardiovasculardiseases. Emerging evidence suggests that environmental exposures in early life may be key riskfactors for cardiovascular conditions across the life span.
As health care professionals, researchers and consumers increasingly use genetic testing, they are uncovering incidental genetic abnormalities, or variants, that are associated with cardiovasculardiseases.
It encompasses several factors, including the strength and efficiency of the heart, the flexibility and health of the blood vessels, and the ability of the cardiovascular system to deliver oxygen and nutrients to the body’s tissues.
a child with riskfactors for heartdisease (high blood pressure, overweight, etc.) This is precious time that could be spent managing their conditions to help them avoid having a heart attack or stroke at a young age. Today in the U.S., A new study from Northwestern University and the Ann & Robert H.
Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. fold higher risk for cardiac mortality and 5.5-fold
Genome-wide association and Mendelian randomisation studies have identified lipoprotein(a) (Lp[a]) as an emerging riskfactor for calcific aortic stenosis and a causal riskfactor for atherosclerotic cardiovasculardisease (ASCVD) in different ethnicities.
A total of 154 patients (median age 62 years, 42% women) with high triglyceride levels and other riskfactors for cardiovasculardisease participated in the study at 24 sites in the U.S. and Canada. Patients’ median triglyceride level was 242 mg/dL.
Regular physical activity is a cornerstone of a healthy lifestyle, and its positive effects on heart health are widely recognized. Engaging in exercise can significantly contribute to maintaining a healthy heart and reducing the risk of cardiovasculardiseases. However, like all good things, balance is key.
Abstract Gene therapy has recently become a reality in the treatment of cardiovasculardiseases. This scientific statement provides a comprehensive overview of the various modalities of gene therapy used to treat heart failure and some of its riskfactors, and their application in the clinical setting.
Introduction The independent and causal cardiovasculardiseaseriskfactor lipoprotein(a) (Lp(a)) is elevated in >1.5 billion individuals worldwide, but studies have prioritised European populations. Causal effects of increased Lp(a) with increased glycated haemoglobin were estimated for Europeans (p value =1.4
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content